Skip to content
Jun 15 2021

ECASS III

Core Landmark Research, EBM, Landmark Research
Alteplase may be safely administered in treatment of acute ischemic stroke in the extended period of 3 to 4.5 hours after symptom onset
Read more

January 2020

  • Olive View Internal Medicine Residency

Validation and Refinement of Scores to Predict Very Early Stroke Risk after TIA

Read more

May 2019

  • Olive View Internal Medicine Residency

Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke

Read more

January 2019

  • Olive View Internal Medicine Residency

Here are this month's articles: Dexamethasone in Adults with Bacterial Meningitis Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Read more
Back To Top
Login
Log in below to access learning modules.
Forgot Password
Enter your email address or username and we’ll send you instructions to reset your password.